comparemela.com

Georges Gebrael News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ICI-Treated Synchronous mRCC Is Associated With Negative Survival Outcomes

Patients with synchronous metastatic renal cell carcinoma who received first-line immunotherapy had worse survival outcomes compared with those with metachronous metastatic renal cell carcinoma.

United statesGeorges gebraelEnd results programInternational metastaticInternational metastatic renal cell carcinoma databaseDivision of medical oncologyDepartment of internal medicineNational cancer institute surveillanceDatabase consortiumKidney cancer research summitCancer researchMedical oncologyInternal medicineUtah huntsman cancer instituteSalt lake cityEnd results

Smoking Does Not Affect Outcomes of Immunotherapy-Based mRCC Treatments

Unlike some other cancers, smoking status was not predictive in mRCC treated with first-line immunotherapy combinations.

United statesUniversity of utahSalt lake cityGeorges gebraelInternational metastatic renal cell carcinoma database consortiumHuntsman cancer instituteAmerican society of clinical oncologyAmerican societyClinical oncologyKarnofsky performance

vimarsana © 2020. All Rights Reserved.